RECRUITING

Pediatric cGVHD Symptom Scale

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Background: Some children/adolescents who have had a stem cell transplant live with chronic graft-versus-host-disease (cGVHD). cGVHD is a side effect of the transplant that can cause multiple bothersome symptoms and negatively affect a child/adolescent squality of daily life. The questionnaires that measure thesymptoms caused by cGVHD are designed for adults. Children/adolescents may not describe their symptoms in the same way. The goal of this research is to improve the way we measure how bothersome these symptoms are for children/adolescents living with cGVHD. Objective: To develop a questionnaire (The Pediatric cGHVD Symptom Scale) for children/adolescents living with cGVHD to identify the symptoms they are experiencing and describe how bothersome those symptoms are to them. An additional goal is to design a parent/guardian companion questionnaire that can be used to capture the symptom experiences of very young children who may not be able to complete a questionnaire. Eligibility: Children/adolescents ages 5-17 who are receiving treatment for cGVHD after a stem cell transplant, and their parent/guardian.. Design: This study consists of 2 projects. Children/adolescents with cGVHD and their parent/guardianparticipants will be grouped by the child/adolescent s age: 5-7, 8-12, and 13-17. In project 1, participants will complete an age-appropriate questionnaire about cGVHD symptoms. The questionnaire will ask about the child/adolescent s physical functioning and emotional well-being. The parent/guardian will out fill out a companion questionnaire online. The child/adolescent will then review their completed questionnaire during an interview with a researcher and will be asked whether the questions about their symptoms were difficult to understand. The parent/guardian and child/adolescent will then be interviewed together to further explore their responses to the questionnaires. Interviews will be done in person, by phone, and online. . Based on what is learned through these interviews, the wording of the questionnaire will be improved for better comprehension and ease of response. In project 2, participants will complete this revised questionnairefor their age group along with some other questionnaires that ask about quality of life. Both the child/adolescent and parent/guardian will fill out the questionnaires online at three separate time points. In both projects, children/adolescents with cGVHD and their parent/guardian participants will be grouped by the child/adolescent s age: 5-7, 8-12, and 13-17. ...

Official Title

Development and Psychometric Testing of a Pediatric Chronic Graft- Versus-Host Disease (GVHD) Symptom Scale (PCSS)

Quick Facts

Study Start:2019-10-02
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04044365

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:5 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Lori Wiener, Ph.D.
CONTACT
(240) 760-6419
lori.wiener@nih.gov

Principal Investigator

Lori Wiener, Ph.D.
PRINCIPAL_INVESTIGATOR
National Cancer Institute (NCI)

Study Locations (Sites)

Children's Hospital Colorado (CHCO)
Aurora, Colorado, 80045
United States
Children s National Medical Center (CNMC)
Washington, District of Columbia, 20010
United States
Children's Healthcare of Atlanta - Egleston Hospital
Atlanta, Georgia, 30322
United States
Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611
United States
Johns Hopkins Hospital (JHH)
Baltimore, Maryland, 21287
United States
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892
United States
University of Minnesota
Minneapolis, Minnesota, 55455
United States
St. Jude Children s Research Hospital
Memphis, Tennessee, 38105
United States
Texas Children's Hospital (TCH)-Baylor
Houston, Texas, 77030
United States
The University of Texas MD Anderson Cancer Institute
Houston, Texas, 77030
United States
Fred Hutchinson Cancer Center (FHCC)
Seattle, Washington, 98109
United States

Collaborators and Investigators

Sponsor: National Cancer Institute (NCI)

  • Lori Wiener, Ph.D., PRINCIPAL_INVESTIGATOR, National Cancer Institute (NCI)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-10-02
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2019-10-02
Study Completion Date2025-12-31

Terms related to this study

Keywords Provided by Researchers

  • Hematopoietic Stem Cell Transplantation (HSCT)
  • Allogeneic Stem Cell Transplant
  • Phototherapies
  • Graft Vs Host Disease
  • Natural History

Additional Relevant MeSH Terms

  • Graft vs Host Disease